This stock is no longer traded. It was delisted on July 28, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
Avalon GloboCare Corp. is a commercial-stage company focused on developing and delivering precision diagnostic consumer products, advancing cellular therapy intellectual property, and owning commercial real estate properties in the United States. It markets the KetoAir™ breathalyzer, a handheld nanosensor device that measures breath acetone levels to monitor ketosis and fat metabolism, integrated into wellness programs for first responders and ketogenic health management. The company distributes KetoAir™ through wholesale agreements, affiliate programs, and online channels in the United States and United Kingdom, while co-developing additional applications like a cannabis breathalyzer for point-of-care detection. Avalon GloboCare Corp. advances proprietary CAR-T and CAR-NK cell technologies, including bispecific designs and cytokine induction methods protected by patents in multiple jurisdictions. Through subsidiaries like Avalon Quantum AI, LLC and Q&A Distribution, LLC, it operates generative AI software for nutrition and publishing, alongside real estate operations. Founded in 2015 and headquartered in Freehold, New Jersey, Avalon GloboCare Corp. plays a role in the intersection of diagnostics, biotech IP, AI-enabled health tools, and property management within healthcare and real estate markets.
Website4400 Route 9 South
Freehold, NJ, 07728
United States
Summary of Jul 21's posts. Generated by AI.
Summary of Apr 21's posts. Generated by AI.
Summary of Apr 21's posts. Generated by AI.
Investors talking about ALBT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.